Cover Image

Design, Synthesis, and Evaluation of New Polyhydroxylated B is ‐Chalcones as Potential COX‐2 Selective Inhibitors

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Rui Pereira, Alberto N. Araújo, Daniela Ribeiro, Ismael Rufino, Nuno Martinho, Rita C. Guedes, Vera L. M. Silva, Eduarda Fernandes
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	ChemMedChem
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Decoding Urease Inhibition: A Comprehensive Review of Inhibitor Scaffolds
by: Nuno Martinho, et al.
Published: (2026)

Carborane‐Based Analogs of Celecoxib and Flurbiprofen, their COX Inhibition Potential, and COX Selectivity Index
by: Lea Ueberham, et al.
Published: (2025)

Front Cover: Carborane‐Based Analogs of Celecoxib and Flurbiprofen, their COX Inhibition Potential, and COX Selectivity Index (ChemMedChem 11/2025)
by: Lea Ueberham, et al.
Published: (2025)

Styrylchromones: Biological Activities and Structure‐Activity Relationship
by: Mariana Lucas, et al.
Published: (2024)

Design, Synthesis, and Biological Characterization of Macromolecular Ester Prodrugs of a Selective Cyclooxygenase‐2 Inhibitor
by: Mario Saletti, et al.
Published: (2025)

Rational Design of Novel Allosteric EYA2 Inhibitors as Potential Therapeutics for Multiple Brain Cancers
by: Lukas Gardner, et al.
Published: (2024)

Next‐Generation Bcl‐2 Inhibitors: Design and Evaluation of Indolyl‐Triazole Derivatives with Anticancer Potential
by: Ahmed M. Almehdi, et al.
Published: (2025)

Design, Synthesis, and Evaluation of Novel Inhibitors of Aminoglycoside‐Resistance 16S Ribosomal RNA Methyltransferases
by: Benjamin E. Deprez, et al.
Published: (2025)

Front Cover: Rational Design of Novel Allosteric EYA2 Inhibitors as Potential Therapeutics for Multiple Brain Cancers (ChemMedChem 18/2024)
by: Lukas Gardner, et al.
Published: (2024)

Front Cover: Rational Design and Synthesis of Isatin‐Chalcone Hybrids Integrated with 1H‐1,2,3‐Triazole: Anti‐Proliferative Profiling and Molecular Docking Insights (ChemMedChem 14/2024)
by: Swati, et al.
Published: (2024)

Exploration of 3‐Substituted Benzofuran‐Tethered Sulfamoyl Triazoles as Carbonic Anhydrase Inhibitors: Design, Synthesis, and Biological Evaluation
by: Anuradha Singampalli, et al.
Published: (2025)

Targeting Ubiquitin‐Specific Protease 7 with Novel 5‐Amino‐Pyrazole Inhibitors: Design, Synthesis, and Biological Evaluation
by: Matteo Lusardi, et al.
Published: (2025)

Design and Synthesis of Novel β‐Carboline‐Bisindole Hybrids as Potential Anticancer Agents
by: Nguyen Thi Thanh Huyen, et al.
Published: (2024)

Structure‐Atropisomer Stability Relationship in Selective MCL‐1 Inhibitors
by: Szabolcs Sipos, et al.
Published: (2025)

Gram‐Scale Synthesis of an Arylsulfonamide‐Type Alkaline Phosphatase Inhibitor
by: Zsolt Rapi, et al.
Published: (2026)

Front Cover: Fragment‐Based Design, Synthesis, and Characterization of Aminoisoindole‐Derived Furin Inhibitors (ChemMedChem 9/2024)
by: Roman W. Lange, et al.
Published: (2024)

Design and Synthesis of Pyrimidino[4,5‐ d ]Pyrimidine‐Based Compounds as Potent B‐RAF V600E Inhibitors
by: Eleftheria A. Georgiou, et al.
Published: (2026)

Design, Synthesis, and Evaluation of Novel Syncarpic Acid Derivatives as Potential Anti‐Inflammatory Agents
by: Revoju Sravanthi, et al.
Published: (2026)

In Silico‐Enabled Discovery and Development of Potent and Selective CDK11 Inhibitors
by: Frankie S. Mak, et al.
Published: (2026)

Design, Synthesis, and Biological Evaluation of Novel Triazine‐Based Dual Histone Deacetylase/phosphatidylinositol 3‐kinase Inhibitors for Breast Cancer Therapy
by: Lara Luzietti, et al.
Published: (2026)

Design and Synthesis of Potent Ridaifen Analogues: Evaluation as Anticancer, 20S Proteasomal Inhibitors, and Antiebola Virus Agents through In vitro and In Silico Studies
by: Merna A. Vector, et al.
Published: (2025)

Design and Synthesis of Sulfonium and Selenonium Derivatives Bearing 3′,5′‐ O ‐Benzylidene Acetal Side Chains as Potent α ‐Glucosidase Inhibitors
by: Yaojia Li, et al.
Published: (2025)

Crystallographic and Selectivity Studies on the Approved HIF Prolyl Hydroxylase Inhibitors Desidustat and Enarodustat
by: Thomas P. Corner, et al.
Published: (2024)

Exploring Coumarin‐Triazole Derivatives as Selective Inhibitors of Carbonic Anhydrase IX and XII
by: Vadakattu Manasa, et al.
Published: (2026)

Identification of Potential Inhibitors of the SARS‐CoV‐2 NSP13 Helicase via Structure‐Based Ligand Design, Molecular Docking and Nonequilibrium Alchemical Simulations
by: Giorgio Di Paco, et al.
Published: (2024)

Design, Synthesis, and Biological Evaluation of Small‐Molecule PD‐1/PD‐L1 Inhibitors Bearing a Rigid Benz[d]oxazole Skeleton
by: Bo Wei, et al.
Published: (2026)

Benzofurans as Acetylcholinesterase Inhibitors for Treating Alzheimer's Disease: Synthesis, in vitro Testing, and in silico Analysis
by: Arturo Coaviche‐Yoval, et al.
Published: (2024)

Discovery of Galactopyranose‐1‐carboxamides as a New Class of Small, Novel, Potent, Selective, and Orally Active Galectin‐3 Inhibitors
by: Cornelia Zumbrunn, et al.
Published: (2025)

Design and Synthesis of New Pyrazolo[1,5‐ c ]quinazolin‐5‐amines as Potential TLR7/8 Modulators
by: Kushvinder Kumar, et al.
Published: (2026)

Investigations on Antiproliferative Potential of Thiosemicarbazone Zn(II) Complexes: Design, Synthesis, and Density Functional Theory Studies on Structural Parameters
by: Shivendra K. Pandey, et al.
Published: (2025)

Synthesis of 2‐Aryl(alkyl)benzimidazole Hydroxamic Acids as HDAC Inhibitors with Anti‐Angiogenesis Properties
by: Yi‐Ting Liu, et al.
Published: (2026)

Divergent Synthesis of Novel 3(5)‐Aminoazole–Benzopyrone Hybrids and their Evaluation as α‐Glucosidase Inhibitors
by: Andrii S. Myshko, et al.
Published: (2024)

Effective Anticancer Potential of a New Sulfonamide as a Carbonic Anhydrase IX Inhibitor Against Aggressive Tumors
by: Ismail Koyuncu, et al.
Published: (2024)

Evaluating Bis‐Phenacyl Bromide‐Based Bis‐Heterocyclic Templates as Anticancer Prototypes and Potential PARP1 Inhibitors
by: Refaie M. Kassab, et al.
Published: (2025)

Design, Synthesis, and Biological Evaluation of Indolin‐2‐One–Matrine Derivatives as Potential VEGFR‐2‐Targeting Agents for Hepatocellular Carcinoma
by: Ziyi Wang, et al.
Published: (2026)

Tailored Tetrasubstituted Imidazole Carrying the Benzenesulfonamide Fragments as Selective Human Carbonic Anhydrase IX/XII Inhibitors
by: Ehab S. Taher, et al.
Published: (2024)

Design and Synthesis of 2‐Nitroimidazole‐1,2,3‐triazole Sulfonamide Hybrids as Potent and Selective Anti‐Trypanosomatid Agents
by: Victória C. Tietz, et al.
Published: (2024)

Synthesis, Biological Evaluation, and Theoretical Study of Indenoquinolinylphosphine Oxide Derivatives as Topoisomerase 1 Inhibitors and Antiproliferative Agents
by: Alba Rodriguez, et al.
Published: (2026)

An Internal Sulfur–Lone Pair Interaction Enabled the Discovery of Potent and Sub‐Family Selective PKMYT1 Inhibitors
by: Yazhou Wang, et al.
Published: (2026)

Synthesis and Characterization of DHODH Inhibitors Based on the Vidofludimus Scaffold with Pronounced Anti‐SARS‐CoV‐2 Activity
by: Christian Gege, et al.
Published: (2024)